Enhanced Lignanamide Absorption and Antioxidative Effect of Extruded Hempseed (Cannabis sativa L.) Hull in Caco-2 Intestinal Cell Culture

2021 ◽  
Vol 69 (38) ◽  
pp. 11259-11271
Author(s):  
William Leonard ◽  
Yun Xiong ◽  
Pangzhen Zhang ◽  
Danyang Ying ◽  
Zhongxiang Fang
2018 ◽  
Vol 92 (9) ◽  
Author(s):  
Mayumi K. Holly ◽  
Jason G. Smith

ABSTRACTHuman adenoviruses (HAdV) are significant human pathogens. Although only a subset of HAdV serotypes commonly cause gastroenteritis in humans, most HAdV species replicate in the gastrointestinal tract. Knowledge of the complex interaction between HAdVs and the human intestinal epithelium has been limited by the lack of a suitable cell culture system containing relevant cell types. Recently, this need has been met by the stable and prolonged cultivation of primary intestinal epithelial cells as enteroids. Human enteroids have been used to reveal novel and interesting aspects of rotavirus, norovirus, and enterovirus replication, prompting us to explore their suitability for HAdV culture. We found that both prototype strains and clinical isolates of enteric and nonenteric HAdVs productively replicate in human enteroids. HAdV-5p, a respiratory pathogen, and HAdV-41p, an enteric pathogen, are both sensitive to type I and III interferons in human enteroid monolayers but not A549 cells. Interestingly, HAdV-5p, but not HAdV-41p, preferentially infected goblet cells. And, HAdV-5p but not HAdV-41p was potently neutralized by the enteric human alpha-defensin HD5. These studies highlight new facets of HAdV biology that are uniquely revealed by primary intestinal epithelial cell culture.IMPORTANCEEnteric adenoviruses are a significant cause of childhood gastroenteritis worldwide, yet our understanding of their unique biology is limited. Here we report robust replication of both prototype and clinical isolates of enteric and respiratory human adenoviruses in enteroids, a primary intestinal cell culture system. Recent studies have shown that other fastidious enteric viruses replicate in human enteroids. Therefore, human enteroids may provide a unified platform for culturing enteric viruses, potentially enabling isolation of a greater diversity of viruses from patients. Moreover, both the ability of interferon to restrict respiratory and enteric adenoviruses and a surprising preference of a respiratory serotype for goblet cells demonstrate the power of this culture system to uncover aspects of adenovirus biology that were previously unattainable with standard cell lines.


2012 ◽  
Vol 27 (6) ◽  
pp. 405-413 ◽  
Author(s):  
Jakob Müller ◽  
Natalie Gruner ◽  
Isabella Almstätter ◽  
Frauke Kirsch ◽  
Andrea Buettner ◽  
...  

2021 ◽  
Vol 12 ◽  
Author(s):  
Veronica Cocetta ◽  
Paolo Governa ◽  
Vittoria Borgonetti ◽  
Mattia Tinazzi ◽  
Gregorio Peron ◽  
...  

The relevance and incidence of intestinal bowel diseases (IBD) have been increasing over the last 50 years and the current therapies are characterized by severe side effects, making essential the development of new strategies that combine efficacy and safety in the management of human IBD. Herbal products are highly considered in research aimed at discovering new approaches for IBD therapy and, among others, Cannabis sativa L. has been traditionally used for centuries as an analgesic and anti-inflammatory remedy also in different gastrointestinal disorders. This study aims to investigate the effects of different C. sativa isolated compounds in an in vitro model of intestinal epithelium. The ability of treatments to modulate markers of intestinal dysfunctions was tested on Caco-2 intestinal cell monolayers. Our results, obtained by evaluation of ROS production, TEER and paracellular permeability measurements and tight junctions evaluation show Cannabidiol as the most promising compound against intestinal inflammatory condition. Cannabidiol is able to inhibit ROS production and restore epithelial permeability during inflammatory and oxidative stress conditions, suggesting its possible application as adjuvant in IBD management.


Author(s):  
Yula Sambruy ◽  
S. Ferruzza ◽  
G. Ranaldi ◽  
I. De Angelis

2007 ◽  
Vol 72 (4) ◽  
pp. 398-408 ◽  
Author(s):  
O. P. Zhirnov ◽  
I. V. Vorobjeva ◽  
O. A. Saphonova ◽  
N. A. Malyshev ◽  
A. V. Ovcharenko ◽  
...  

PLoS ONE ◽  
2013 ◽  
Vol 8 (6) ◽  
pp. e63485 ◽  
Author(s):  
Efstathia Papafragkou ◽  
Joanne Hewitt ◽  
Geun Woo Park ◽  
Gail Greening ◽  
Jan Vinjé

1994 ◽  
Vol 2 (1-2) ◽  
pp. 36-38 ◽  
Author(s):  
C.L. Laboisse ◽  
A. Jarry ◽  
C. Bou-Hanna ◽  
D. Merlin ◽  
G. Vallette

Sign in / Sign up

Export Citation Format

Share Document